SCHEMBL7084119

SCHEMBL7084119

COCCN(C)C(=O)c1cn(C(c2cnc[nH]2)[C@H](C)c2ccccc2)cc1-c1cccc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
FNTA P49354 13/20 0.44
FNTB P49356 13/20 0.44
PGGT1B P53609 3/20 0.44
HTR2C P28335 1/20 0.42
ADRA2A P08913 4/20 0.35
ADRA2B P18089 4/20 0.35
ADRA2C P18825 4/20 0.35
ADRA1A P35348 2/20 0.35
MAPK14 Q16539 1/20 0.35
ADRA1D P25100 1/20 0.35
ADRA1B P35368 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7084240 1.00 FNTA (0.44) FNTAFNTBPGGT1BHTR2CADRA2A
SCHEMBL6927124 0.84 FNTA (0.47) FNTAFNTBPGGT1BHTR2CADRA2A
SCHEMBL7675140 0.84 HTR2C (0.42) FNTAFNTBPGGT1BHTR2CADRA2A
SCHEMBL7547465 0.81 FNTA (0.41) FNTAFNTBPGGT1BHTR2C
SCHEMBL7512901 0.80 FNTA (0.45) FNTAFNTBPGGT1BHTR2CADRA2A
SCHEMBL6983262 0.79 HTR2C (0.45) FNTAFNTBPGGT1BHTR2CADRA2A
SCHEMBL7503289 0.78 FNTA (0.44) FNTAFNTBPGGT1BHTR2C
SCHEMBL7509342 0.78 FNTA (0.42) FNTAFNTBPGGT1BHTR2C
SCHEMBL7508235 0.78 FNTA (0.43) FNTAFNTBPGGT1BHTR2CMAPK14
SCHEMBL6974495 0.78 FNTA (0.49) FNTAFNTBPGGT1BHTR2CADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045846-B1 IMIDAZOLE DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE AND PROCESS FOR PREPARATION THEREOF LG CHEMICAL LTD (KR) 2003-05-02 EP claimed
US-6472526-B1 SHOWS AN INHIBITORY ACTIVITY AGAINST FARNESYL TRANSFERASE OR PHARMACEUTICALLY ACCEPTABLE SALTS OR ISOMERS THEREOF, IN PHARMACEUTICAL COMPOSITION AND INTERMEDIATES LG CHEMICAL LTD. (KR) 2002-10-29 US disclosed